Funding Opportunity Announcements for the RADx-UP Initiatives

June 1, 2020

NIH issued a Notice of Intent to Publish (NOITP) four Funding Opportunity Announcements as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, a $500 million initiative to reduce COVID-19 associated morbidity and mortality disparities for vulnerable and underserved populations that are disproportionately affected by COVID-19.

The NOITP can be found on the NIH website: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-112.html

The FOAs, in which NCATS will be participating, will include three Notices of Special Interest to solicit community-engaged research to understand COVID-19 disparities and increase access to and effectiveness of diagnostic testing interventions among underserved and vulnerable populations and to understand the social, ethical, and behavioral implications of testing in these populations. An RFA to support a Coordination and Data Collection Center (CDCC) will also be announced.

The FOAs are expected to be published in early June. First Estimated Application Due Date will be in July 2020.  Applications will be accepted through August 2020 for FY20 funding. Earliest Estimated Award Date will be in September 2020.

NCATS Point of Contact:  Xinzhi Zhang, xinzhi.zhang@nih.gov

Additional Details (for the announcement, that the newsletter link and Derek’s link can point to)

NIH plans to publish three (3) NOSIs for competitive revision awards as follows:

  1. To solicit emergency competitive revision applications to existing awards for large consortia, multi-site trials, centers, and other current networks that have adequate capacity, infrastructure, and established community-engaged relationships to support large-scale testing interventions or that have the capacity to ramp up quickly to reach underserved or vulnerable populations.
  2. Similar to the above, but shifts eligibility to collaborative and individual research awards, generally focused on smaller underserved or vulnerable populations.
  3. To solicit research to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing in these populations.

The fourth funding opportunity using the U24 activity code will be announced for a Coordination and Data Collection Center (CDCC), a key component of the consortium.